Tag Archives: Jefferies

Aurora Cannabis (ACB) Gets an Underperform Rating from Jefferies

Jefferies analyst Owen Bennett reiterated an Underperform rating on Aurora Cannabis (NYSE: ACB) on December 31 and set a price target of C$4.59. The company’s shares closed last Monday at $9.52. Currently, the analyst consensus on Aurora Cannabis is a

Analysts Offer Insights on Services Companies: and Discovery (NASDAQ: DISCK)

Analysts fell to the sidelines weighing in on and Discovery (DISCK – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. TipRanks has tracked 36,000 company insiders and found that a few

Analysts Are Bullish on These Financial Stocks: Jefferies (JEF), DraftKings (DKNG)

There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Jefferies (JEF – Research Report) and DraftKings (DKNG – Research Report) with bullish sentiments. Jefferies (JEF) Oppenheimer analyst Chris Kotowski assigned a

Jefferies Reiterates Buy on Bio-Rad Laboratories Shares, Sees 35% Upside For The Stock

In a research report issued on 8/31, Jefferies analyst Brandon Couillard reiterated a Buy rating on Bio-Rad Laboratories (NYSE:BIO)with a price target of $666, which represents a potential upside of 35% from where the stock is currently trading. According to

Oppenheimer Sticks to Its Buy Rating for Jefferies (JEF)

Oppenheimer analyst Chris Kotowski maintained a Buy rating on Jefferies (JEF – Research Report) today and set a price target of $30.00. The company’s shares closed last Monday at $22.51, close to its 52-week high of $22.70. According to TipRanks.com,

Oppenheimer Maintains a Buy Rating on Jefferies (JEF)

Oppenheimer analyst Chris Kotowski maintained a Buy rating on Jefferies (JEF – Research Report) today and set a price target of $30. The company’s shares opened today at $20.27. Kotowski said: “Jefferies reported 4Q18 earnings on January 10 with all